{"organizations": [], "uuid": "2e9dc43bde9685625003b435be18afd41930e179", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/img/WSJ_Logo_black_social.gif", "site_section": "https://www.wsj.com/europe", "section_title": "The Wall Street Journal &amp; Breaking News, Business, Financial and Economic News, World News and Video", "url": "https://www.wsj.com/articles/axovant-stock-tumbles-after-sweeping-leadership-changes-1518452146", "country": "US", "domain_rank": 387, "title": "Axovant Stock Tumbles After Sweeping Leadership Changes", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-02-12T21:09:00.000+02:00", "replies_count": 0, "uuid": "2e9dc43bde9685625003b435be18afd41930e179"}, "author": "Imani Moise", "url": "https://www.wsj.com/articles/axovant-stock-tumbles-after-sweeping-leadership-changes-1518452146", "ord_in_thread": 0, "title": "Axovant Stock Tumbles After Sweeping Leadership Changes", "locations": [], "entities": {"persons": [{"name": "david hung", "sentiment": "none"}], "locations": [], "organizations": [{"name": "axovant sciences ltd.", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Axovant Sciences Ltd. made sweeping changes to its top ranks Monday as the company struggles to regain its footing after abandoning its banner Alzheimerâ€™s drug.\nShares plunged 20% to $1.54 during morning trading, and are down 88% from a year ago.\nChief Executive David Hung has resigned after 10 months in his role, but will continue to serve... To Read the Full Story Subscribe Sign In", "external_links": [], "published": "2018-02-12T21:09:00.000+02:00", "crawled": "2018-02-13T08:50:02.003+02:00", "highlightTitle": ""}